Latest News and Press Releases
Want to stay updated on the latest news?
-
Potential world-first patented biomarker for long COVID Evaluating diagnostic companion with Bucillamine for long COVID TORONTO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd....
-
Dyadic to Present at Industry Events in November
-
JUPITER, Fla., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
-
Prompted by advice from FDA regarding study design, 60P Australia Pty Ltd, a majority-owned subsidiary of 60 Degrees Pharmaceuticals, has withdrawn its IND for ACLR8-LR, a Phase IIB study of the use...
-
New York, United States, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Personal hygiene is maintaining one's health and hygiene to prevent infectious diseases, fungi, and other illnesses. Regular hand washing,...
-
CHICAGO, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Beginning September 16th, Walgreens, a pharmacy and retail leader who plays a critical role in the U.S. healthcare system by providing a wide range of...
-
TUCSON, Ariz., Sept. 13, 2023 (GLOBE NEWSWIRE) -- As masking mandates are being reintroduced in schools and medical facilities, the Association of American Physicians and Surgeons (AAPS) issued a...
-
TUCSON, Ariz., Aug. 30, 2023 (GLOBE NEWSWIRE) -- The SARS-CoV-2 spike protein found in cells and tissues after COVID-19 respiratory illness and COVID-19 vaccination, which is thought to account for...
-
Wilmington, Delaware, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Market Scope and Report Overview Organizations that are driving market expansion have been making more developments. For instance, in...
-
ACLR8-LR, a double-blind, randomized, placebo-controlled Phase IIB study to determine efficacy of the ARAKODA® regimen of tafenoquine in COVID-19 patients with mild-moderate symptoms and low risk of...